Eucabal (acetylcysteine) powder 600 mg. №20

$29.00

Manufacturer: Germany

Purpose: Acetylcysteine thins mucus, used for respiratory conditions like COPD.

SKU: MED58292 Category:

Description

Eucabal (Acetylcysteine) Powder 600 mg. №20

Composition

Each packet contains:

  • Acetylcysteine 600 mg

Mechanism of Action

Acetylcysteine functions as a mucolytic agent by disrupting disulfide bonds in mucus, reducing its viscosity and facilitating clearance from the respiratory tract.

Pharmacological Properties

Acetylcysteine exhibits antioxidant and anti-inflammatory properties in addition to its mucolytic effects, contributing to its therapeutic benefits in respiratory conditions.

Indications for Use

Eucabal (Acetylcysteine) powder is indicated for:

  • Relief of respiratory conditions associated with thick mucus.
  • Supporting respiratory health.

Contraindications

Do not use Eucabal (Acetylcysteine) powder if:

  • You are allergic to acetylcysteine.
  • You are pregnant or breastfeeding without consulting a healthcare professional.

Side Effects

Common side effects may include gastrointestinal disturbances such as nausea and vomiting. Allergic reactions to acetylcysteine are rare but possible.

Usage Instructions

For optimal results:

  • Dissolve the contents of one packet in water and take orally once a day.
  • Adhere to the dosage recommended by your healthcare provider.

Benefits Compared to Analogues

Eucabal (Acetylcysteine) powder offers a well-established mucolytic and respiratory support profile, backed by clinical evidence of effectiveness and safety.

Suitable Patient Groups

Eucabal is suitable for adults, including the elderly, who require respiratory support due to mucus-related conditions.

Storage and Shelf Life

Store Eucabal (Acetylcysteine) powder in a cool, dry place away from sunlight. Check the expiration date on the packaging and do not use after that date.

Packaging Description

The product is available in packets containing 600 mg of Acetylcysteine powder, with each box containing 20 individual packets.

Clinical Evidence and Proven Effectiveness

Acetylcysteine has been extensively studied for its mucolytic properties. It has shown efficacy in improving symptoms in patients with chronic bronchitis and other respiratory conditions. Clinical trials have demonstrated its effectiveness in reducing exacerbations and improving lung function in individuals with chronic obstructive pulmonary disease (COPD). Additionally, research suggests that acetylcysteine’s antioxidant and anti-inflammatory effects further support its role in enhancing respiratory health.